- GlaxoSmithKlineand Sanofi are to start testing their protein-based Covid-19 vaccine on humans for the first time.
- Furthermore, results of the trial are expected to arrive in early December 2020.
- The two pharmaceutical companies are scaling up their manufacturing units to achieve an all time high of $1bn doses in production.
- In Addition, the US government agreed to provide funds to speed up the development process, in return for 100m doses of the vaccine, if effective.
- They are also looking to...
https://mfame.guru/worlds-largest-vaccine-makers-to-begin-human-testing-in-the-us-with-eye-on-rollout-in-early-2021/